Sydney Morning HeraldGive and you shall receive – new rules give priority to organ donorsSydney Morning HeraldThis involved reaching agreement with Israel's influential but highly sceptical religious leaders on the definition of "brain death&q…
New analysis may help identify breast cancer patients who will benefit from … – News-Medical.net
New analysis may help identify breast cancer patients who will benefit from …News-Medical.netA new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French resea…
'Natural does not equal safe' – Independent Online
Independent Online'Natural does not equal safe'Independent OnlineDr Ulbricht also warned that garlic supplements, which are taken to reduce blood pressure, can interfere with anti-clotting medications and the immunosuppressant drug cyclosporine…
100th Patient Gets a New Heart at Seattle Children's Hospital
5-month-old received this milestone transplant at Children's.
Corneal transplantation – Laser Focus world
Corneal transplantationLaser Focus worldCorneal immunological privilege allows corneal transplantations to remain rejection free, without the use of prophylaxis, in about 80% of low-risk transplantations such as those for keratoconus.54 Corneal transpl…
Even at higher genetic heart risk, lifestyle helps – Fox News
Even at higher genetic heart risk, lifestyle helpsFox NewsThat means increased odds of both heart attack and heart failure. Heart failure is a chronic condition in which the heart can't pump blood efficiently enough to meet the body's demands -…
Abbott Pays Action $110M for Global Rights to Phase II-Stage Acute Kidney … – Genetic Engineering News
The Deal PipelineAbbott Pays Action $110M for Global Rights to Phase II-Stage Acute Kidney …Genetic Engineering NewsAbbott is paying Denmark's Action Pharma $110 million for global rights to develop and commercialize the latter's AP214, a Pha…
Gilead Sciences begins phase III trial of leukaemia drug – Zenopa
Gilead Sciences begins phase III trial of leukaemia drugZenopaThe first patient has been dosed as part of Study 116, a trial that will assess the safety and efficacy of the drug in combination with rituximab among 160 subjects across Europe and the US….
Lupus Nephritis: First ACR Guidelines Published – Medscape
Lupus Nephritis: First ACR Guidelines PublishedMedscapeRituximab or calcineurin inhibitors should be considered if standard treatments fail." Dr. Hahn also noted that an algorithm for management of pregnant woman with active [LN] is included in th…
New biologics and biosimilars approval guidelines in Mexico – The Pharma Letter
New biologics and biosimilars approval guidelines in MexicoThe Pharma LetterFor example, Probiomed already sells six non-originator biologics, including Kikuzubam (rituximab), which is Probiomed's version of Roche's Rituxan/MabThera (rituximab)…